132 related articles for article (PubMed ID: 36948137)
1. The protective effects of a novel AT
Zhang T; Li Y; Wise AF; Kulkarni K; Aguilar MI; Samuel CS; Del Borgo M; Widdop RE; Ricardo SD
Biomed Pharmacother; 2023 May; 161():114556. PubMed ID: 36948137
[TBL] [Abstract][Full Text] [Related]
2. Macrophage angiotensin AT
Fatima N; Ali R; Faisal T; Kulkarni K; Patel S; Hussain T
Am J Physiol Renal Physiol; 2023 Nov; 325(5):F552-F563. PubMed ID: 37615049
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of IL-18 reduces renal fibrosis after ischemia-reperfusion.
Liang H; Xu F; Zhang T; Huang J; Guan Q; Wang H; Huang Q
Biomed Pharmacother; 2018 Oct; 106():879-889. PubMed ID: 30119258
[TBL] [Abstract][Full Text] [Related]
4. Nicotinic acetylcholine receptor agonist reduces acute lung injury after renal ischemia-reperfusion injury by acting on splenic macrophages in mice.
Goto D; Nagata S; Naito Y; Isobe S; Iwakura T; Fujikura T; Ohashi N; Kato A; Miyajima H; Sugimoto K; Yasuda H
Am J Physiol Renal Physiol; 2022 May; 322(5):F540-F552. PubMed ID: 35311383
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment with a novel Toll-like receptor 4 agonist attenuates renal ischemia-reperfusion injury.
Hernandez A; Patil NK; Brewer M; Delgado R; Himmel L; Lopez LN; Bohannon JK; Owen AM; Sherwood ER; de Caestecker MP
Am J Physiol Renal Physiol; 2023 May; 324(5):F472-F482. PubMed ID: 36995924
[TBL] [Abstract][Full Text] [Related]
6. Antithrombin III prevents progression of chronic kidney disease following experimental ischaemic-reperfusion injury.
Yin J; Wang F; Kong Y; Wu R; Zhang G; Wang N; Wang L; Lu Z; Liang M
J Cell Mol Med; 2017 Dec; 21(12):3506-3514. PubMed ID: 28767184
[TBL] [Abstract][Full Text] [Related]
7. The Ischemia and Reperfusion Injury Involves the Toll-Like Receptor-4 Participation Mainly in the Kidney Cortex.
Herrera-Luna Y; Lozano M; Pasten C; Multhoff G; Irarrázabal CE
Cell Physiol Biochem; 2022 Nov; 56(6):613-628. PubMed ID: 36378153
[TBL] [Abstract][Full Text] [Related]
8. [Mesenchymal stem cells attenuate acute kidney injury via regulation of natural immune system].
Hu J; Zhang L; Cui S; Zhu F; Li D; Feng Z; Chen X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Mar; 28(3):235-40. PubMed ID: 29917337
[TBL] [Abstract][Full Text] [Related]
9. TSC1 Affects the Process of Renal Ischemia-Reperfusion Injury by Controlling Macrophage Polarization.
Hu X; Xu Y; Zhang Z; Tang Z; Zhang J; Luo Y; Deng W; Dong Z; Zhao Y; Na N
Front Immunol; 2021; 12():637335. PubMed ID: 33767704
[TBL] [Abstract][Full Text] [Related]
10. Blockade of STAT3 signaling alleviates the progression of acute kidney injury to chronic kidney disease through antiapoptosis.
Park JY; Yoo KD; Bae E; Kim KH; Lee JW; Shin SJ; Lee JS; Kim YS; Yang SH
Am J Physiol Renal Physiol; 2022 May; 322(5):F553-F572. PubMed ID: 35311382
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of taraxasterol on ischemia/reperfusion-induced acute kidney injury via inhibition of oxidative stress, inflammation, and apoptosis.
Li C; Zheng Z; Xie Y; Zhu N; Bao J; Yu Q; Zhou Z; Liu J
Int Immunopharmacol; 2020 Dec; 89(Pt A):107169. PubMed ID: 33183976
[TBL] [Abstract][Full Text] [Related]
12. CXCL16/ROCK1 signaling pathway exacerbates acute kidney injury induced by ischemia-reperfusion.
Liang H; Liao M; Zhao W; Zheng X; Xu F; Wang H; Huang J
Biomed Pharmacother; 2018 Feb; 98():347-356. PubMed ID: 29275176
[TBL] [Abstract][Full Text] [Related]
13. Knockout of Trpa1 Exacerbates Renal Ischemia-Reperfusion Injury With Classical Activation of Macrophages.
Ma S; Wang DH
Am J Hypertens; 2021 Feb; 34(1):110-116. PubMed ID: 33005917
[TBL] [Abstract][Full Text] [Related]
14. Exosome from indoleamine 2,3-dioxygenase-overexpressing bone marrow mesenchymal stem cells accelerates repair process of ischemia/reperfusion-induced acute kidney injury by regulating macrophages polarization.
Xie X; Yang X; Wu J; Tang S; Yang L; Fei X; Wang M
Stem Cell Res Ther; 2022 Jul; 13(1):367. PubMed ID: 35902956
[TBL] [Abstract][Full Text] [Related]
15. STAT1 regulates macrophage number and phenotype and prevents renal fibrosis after ischemia-reperfusion injury.
Kemmner S; Bachmann Q; Steiger S; Lorenz G; Honarpisheh M; Foresto-Neto O; Wang S; Carbajo-Lozoya J; Alt V; Schulte C; Chmielewski S; Bluyssen HAR; Heemann U; Baumann M; Lech M; Schmaderer C
Am J Physiol Renal Physiol; 2019 Feb; 316(2):F277-F291. PubMed ID: 30403164
[TBL] [Abstract][Full Text] [Related]
16. Exogenous hydrogen sulfide and miR-21 antagonism attenuates macrophage-mediated inflammation in ischemia reperfusion injury of the aged kidney.
Pushpakumar S; Kundu S; Weber G; Sen U
Geroscience; 2021 Jun; 43(3):1349-1367. PubMed ID: 33433751
[TBL] [Abstract][Full Text] [Related]
17. Human amniotic epithelial cells ameliorate kidney damage in ischemia-reperfusion mouse model of acute kidney injury.
Ren Y; Chen Y; Zheng X; Wang H; Kang X; Tang J; Qu L; Shao X; Wang S; Li S; Liu G; Yang L
Stem Cell Res Ther; 2020 Sep; 11(1):410. PubMed ID: 32967729
[TBL] [Abstract][Full Text] [Related]
18. Tubular GM-CSF Promotes Late MCP-1/CCR2-Mediated Fibrosis and Inflammation after Ischemia/Reperfusion Injury.
Xu L; Sharkey D; Cantley LG
J Am Soc Nephrol; 2019 Oct; 30(10):1825-1840. PubMed ID: 31315923
[TBL] [Abstract][Full Text] [Related]
19. Liraglutide Attenuates Hepatic Ischemia-Reperfusion Injury by Modulating Macrophage Polarization.
Li SL; Wang ZM; Xu C; Che FH; Hu XF; Cao R; Xie YN; Qiu Y; Shi HB; Liu B; Dai C; Yang J
Front Immunol; 2022; 13():869050. PubMed ID: 35450076
[TBL] [Abstract][Full Text] [Related]
20. Human Endothelial Progenitor Cells Protect the Kidney against Ischemia-Reperfusion Injury via the NLRP3 Inflammasome in Mice.
Jang HN; Kim JH; Jung MH; Tak T; Jung JH; Lee S; Jung S; Chang SH; Kim HJ
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
